Spain occupies a peculiar position in the European investment landscape. It is the fourth-largest eurozone economy, with a GDP exceeding 1.4 trillion euros. It has a sophisticated legal and regulatory framework, world-class infrastructure, and a business fabric of remarkable depth and quality. And yet, the penetration of patient capital — long-horizon, relationship-driven investment in established businesses — remains significantly below that of comparable markets like France, Germany, or the United Kingdom.
This gap is not a weakness. It is an opportunity — arguably the most compelling one available to patient capital investors in Western Europe today.
The macroeconomic case
Spain’s economy has demonstrated remarkable resilience over the past decade. After the severe financial crisis of 2008-2014, the country has achieved sustained GDP growth, reduced unemployment from its peak of 27% to below 11%, and diversified its economic base beyond the traditional pillars of construction and tourism.
The fundamentals are strong: a young, increasingly educated workforce compared to Northern European peers; a strategic geographic position as a bridge between Europe, North Africa, and Latin America; and a cost structure that remains competitive within the eurozone for both labour and real estate.
The family business opportunity
Spain has approximately 1.1 million family businesses, representing 89% of the business fabric, 67% of private employment, and 57% of GDP. This concentration is higher than in France (83%) or Germany (90% by count but with far more professional management).
The critical differentiator is the succession gap. Only 30% of Spanish family businesses survive the transition to the second generation. Tens of thousands of viable, profitable companies face a succession challenge in the coming decade, and the available supply of patient capital to support these transitions is far below the demand.
The fragmentation advantage
Key sectors in the Spanish middle market — logistics, hospitality, healthcare, industrial services, food and beverage — remain highly fragmented. The top ten operators in most sectors control less than 15% of the market. This fragmentation creates consolidation opportunities that can generate significant value through platform strategies.
For patient capital investors, fragmentation is ideal: it allows gradual, methodical consolidation over a ten to twenty-year horizon, building market leaders from a collection of quality family businesses.
The capital gap
Spain’s private capital ecosystem is dominated by two extremes: large international private equity funds that pursue deals above 100 million euros, and venture capital funds focused on technology startups. The middle ground — patient capital for established family businesses with revenues of 10-100 million euros — is dramatically underserved.
This gap means less competition for deals, more reasonable valuations, and a greater ability to add value through active partnership rather than pure financial engineering.
Tax considerations
Spain offers specific tax incentives that benefit patient capital structures. The participation exemption under article 21 of the Corporate Tax Act can eliminate capital gains tax on qualifying share disposals. The family business regime in Wealth Tax and Inheritance Tax provides significant benefits for long-term holdings. And the network of double taxation treaties facilitates cross-border investment structures.
Why we are here
At Blue Mountain, we have been investing exclusively in Spain for over fifteen years — not because we are unaware of other markets, but because we believe Spain offers the best risk-adjusted opportunity for patient capital in Europe. The combination of macroeconomic fundamentals, family business density, sectoral fragmentation, and the relative scarcity of patient capital creates conditions that we have not found replicated elsewhere.
We invest with conviction in a market we know intimately, building relationships with entrepreneurs who value a partner that shares their long-term perspective. And we believe this approach will continue to generate exceptional outcomes — for our portfolio, for the companies we invest in, and for the broader Spanish economic fabric.